Stay updated with breaking news from Rosty Raykov. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DG Capital Management LLC lessened its holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) by 5.9% during the fourth quarter, HoldingsChannel.com reports. The fund owned 1,075,634 shares of the company’s stock after selling 67,465 shares during the period. Fennec Pharmaceuticals makes up about 7.5% of DG Capital Management LLC’s holdings, making the stock its […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) CEO Rosty Raykov sold 40,584 shares of the business’s stock in a transaction dated Wednesday, April 3rd. The shares were sold at an average price of $10.78, for a total transaction of $437,495.52. Following the completion of the sale, the chief executive officer now owns 276,054 shares […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) CEO Rosty Raykov sold 40,584 shares of the stock in a transaction on Wednesday, April 3rd. The shares were sold at an average price of $10.78, for a total transaction of $437,495.52. Following the completion of the sale, the chief executive officer now directly owns 276,054 shares […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC), a biopharmaceutical company focused on the development of PEDMARK for the prevention of platinum-induced ototoxicity in pediatric cancer patients, has reported a significant insider sell transaction.
~ Supports Strategic Discussions and Global Launch Activities ~ ~ Extends Access to Additional Undrawn Capital As Needed During Global PEDMARK® Rollout ~ ~ Facilitates Market Expansion...